prism software v.6.03 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism software v.6.03
Prism Software V.6.03, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+v%2E6%2E03/prism+software/pmc04893864-79-1-4
Average 90 stars, based on 1 article reviews
Prism Software V.6.03, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+software+v%2E6%2E03/prism+software/pmc04893864-79-1-4
Average 90 stars, based on 1 article reviews
prism software v.6.03 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1 Article Snippet: For statistical analyses, we used Article Title: Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis Article Snippet: For statistical analyses, we used Article Title: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1. Article Snippet: We used Article Title: Amorphous nanosilica particles block induction of oral tolerance in mice Article Snippet: All analyses were done using Article Title: Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy Article Snippet: Statistical analyses were performed using Article Title: Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study Article Snippet: Article Title: Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles Article Snippet: All analyses were performed using Article Title: Characterization and optimization of pH-responsive polymer nanoparticles for drug delivery to oral biofilms Article Snippet: Adsorption of NPC to HA and sHA was further analyzed at concentrations of 0–25 mM, and Immunohistochemistry:Article Title: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1 Article Snippet: For statistical analyses, we used Article Title: Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis Article Snippet: For statistical analyses, we used Article Title: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1. Article Snippet: We used Article Title: Amorphous nanosilica particles block induction of oral tolerance in mice Article Snippet: All analyses were done using Article Title: Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy Article Snippet: Statistical analyses were performed using Article Title: Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study Article Snippet: Article Title: Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles Article Snippet: All analyses were performed using Article Title: Characterization and optimization of pH-responsive polymer nanoparticles for drug delivery to oral biofilms Article Snippet: Adsorption of NPC to HA and sHA was further analyzed at concentrations of 0–25 mM, and Adsorption:Article Title: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1 Article Snippet: For statistical analyses, we used Article Title: Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis Article Snippet: For statistical analyses, we used Article Title: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1. Article Snippet: We used Article Title: Amorphous nanosilica particles block induction of oral tolerance in mice Article Snippet: All analyses were done using Article Title: Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy Article Snippet: Statistical analyses were performed using Article Title: Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study Article Snippet: Article Title: Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles Article Snippet: All analyses were performed using Article Title: Characterization and optimization of pH-responsive polymer nanoparticles for drug delivery to oral biofilms Article Snippet: Adsorption of NPC to HA and sHA was further analyzed at concentrations of 0–25 mM, and |